Callan Capital’s Equillium EQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$39.1K Hold
99,688
﹤0.01% 362
2024
Q4
$74.6K Hold
99,688
0.01% 335
2024
Q3
$82.9K Hold
99,688
0.01% 343
2024
Q2
$69.1K Hold
99,688
0.01% 309
2024
Q1
$230K Hold
99,688
0.02% 254
2023
Q4
$72.1K Sell
99,688
-4,000
-4% -$2.38K 0.01% 227
2023
Q3
$76.7K Hold
103,688
0.01% 197
2023
Q2
$77.8K Hold
103,688
0.01% 179
2023
Q1
$75.7K Hold
103,688
0.01% 179
2022
Q4
$110K Buy
+103,688
New +$166K 0.01% 180

Other funds holding EQ

Callan Capital's EQ Position: Q1 2025 in Review

Callan Capital held its Equillium (EQ) position steady in Q1 2025 at 99,688 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Callan Capital first reported a position in EQ in Q4 2022 and has held it in 10 quarters since. The position peaked at $230K in Q1 2024. 24 funds tracked by Wall St. Rank hold EQ as of Q1 2025.

  • Callan Capital held 99,688 shares of Equillium worth $39.1K as of Q1 2025.
  • Callan Capital left its Equillium share count unchanged in Q1 2025.
  • Equillium made up ﹤0.01% of Callan Capital's portfolio in Q1 2025, its #362 holding.
  • Callan Capital first reported a position in Equillium in Q4 2022 and has held it in 10 quarters since.
  • Callan Capital's Equillium position peaked at $230K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held Equillium as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.